Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis

NCT07728201 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Luvometinib
DRUG: Luvometinib, Cytarabine.

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Collaborators

[object Object]